Brugada Syndrome in a Transplanted Heart: Implications for Organ Transplant Screening Process

Circ Genom Precis Med. 2024 Apr 23:e004533. doi: 10.1161/CIRCGEN.123.004533. Online ahead of print.

Authors

Olubadewa A Fatunde^#¹, Pattara Rattanawong^#^{1

2}, Joseph Maleszewski³, David Murray⁴, Win-Kuang Shen¹, Naveen L Pereira²

Affiliations

¹ Department of Cardiovascular Medicine, Mayo Clinic Arizona, Phoenix (O.A.F., P.R., W.-K.S.).
² Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital and Harvard Medical School, Boston (P.R., N.L.P.).
³ Department of Laboratory Medicine and Pathology, Department of Cardiovascular Medicine, Mayo Clinic Rochester, MN (J.M.).
⁴ Department of Medicine, University of Wisconsin, Madison (D.M.).

^# Contributed equally.

PMID: 38651350
DOI: 10.1161/CIRCGEN.123.004533

No abstract available

Keywords: Brugada syndrome; allografts; death, sudden, cardiac; retrospective studies; transplantation.

Publication types

Letter